David Bharucha - 15 Feb 2022 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Chief Medical Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
MIST
Transactions as of
15 Feb 2022
Net transactions value
$0
Form type
4
Filing time
17 Feb 2022, 15:48:06 UTC
Next filing
05 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Employee Stock Option (right to buy) Award $0 +330,000 $0.000000 330,000 15 Feb 2022 Common Shares 330,000 $6.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4th) of the shares subject to the option vest on February 15, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.